
License Agreement By And Between Casi Pharmaceuticals, Inc Form
Use a LICENSE AGREEMENT By And Between CASI PHARMACEUTICALS, INC template to make your document workflow more streamlined.
What this license agreement form does
The License Agreement By And Between Casi Pharmaceuticals, Inc Form records permission for one party to use specified rights, technology, materials, or intellectual property under agreed conditions. The parties identify the licensed subject, permitted activities, territory, duration, payment terms, restrictions, confidentiality duties, ownership provisions, and termination rights. Each party reviews the completed terms, demonstrates intent, signs the record, and keeps an accurate copy. signNow can convert the source document into a fillable workflow, route it to named signers, and preserve the completed agreement with an audit trail.
Who uses this license agreement form
Pharmaceutical teams
Pharmaceutical companies use the form for intellectual-property licenses, research collaborations, technology rights, and commercialization arrangements requiring several approvals.
Internal reviewers
Legal, finance, research, and executive stakeholders review payment terms, licensed scope, confidentiality provisions, and termination rights before execution.
Organizations that use this form
The form fits pharmaceutical licensing workflows where multiple stakeholders must approve rights, restrictions, payments, and confidentiality obligations.
A pharmaceutical startup can use the form to document rights for a compound, platform, or research material while preserving territory, field-of-use, and confidentiality terms. A university technology-transfer office can coordinate inventor, institution, and commercial licensee approvals while maintaining a single executed agreement and searchable audit evidence. An established pharmaceutical enterprise can route agreements through legal, research, finance, and executive reviewers before controlled signature and archival.
These tasks are executed by both individual contributors and centralized administrators depending on organizational policy and required controls.
How the signNow workflow works
Move the completed license agreement from upload to signature while preserving the terms and evidence needed for later review.
Upload document: Upload the license agreement to signNow. Prepare fields: Auto-detect fillable fields, then add missing signature and date fields. Route for signature: Assign parties and send the agreement for signature. Store evidence: Store the executed agreement with its audit trail.
How the audit trail records signing
The audit trail connects each signer’s action to the executed License Agreement By And Between Casi Pharmaceuticals, Inc Form and its final record.
Authenticate signer:
Timestamp event:
Hash document:
Seal record:
Track activity:
Export evidence:
- Best ROI. Our customers achieve an average 7x ROI within the first six months.
- Scales with your use cases. From SMBs to mid-market, airSlate SignNow delivers results for businesses of all sizes.
- Intuitive UI and API. Sign and send documents from your apps in minutes.
Recommended setup for this license agreement
Configure signer identity, signature evidence, access controls, and retention before sending the License Agreement By And Between Casi Pharmaceuticals, Inc Form.
| Setting | Recommendation |
|---|---|
| Authentication method | Email verification with SMS OTP |
| Signature type | Typed or drawn electronic signature |
| Audit trail | Capture timestamps, IP addresses, and actions |
| Document retention | Retain signed records under company policy |
| Encryption | Use TLS 1.2/1.3 and AES-256 |
Platform requirements for this license agreement
Complete the License Agreement By And Between Casi Pharmaceuticals, Inc Form in a current Chrome, Firefox, Safari, or Edge browser using Windows or macOS. signNow mobile apps support document review and signing on iOS and Android.
Browser support Use Chrome, Firefox, Safari, or Edge on Windows or macOS. Operating systems Open the form on Windows 11, macOS, iOS, or Android. Mobile access Use signNow mobile apps on iOS and Android devices.
Organizations should manage access on approved Windows, macOS, iOS, or Android devices and confirm that signers can open the completed license agreement. Enterprise teams may also connect signNow through its API and configure SSO, authentication controls, and retention policies for controlled document handling.
Features for pharmaceutical licensing workflows
signNow combines field preparation, signer routing, audit evidence, mobile access, and storage integrations for this multi-party license agreement.
Assigned fields
Assigns signature, initials, date, and text fields to the parties named in the pharmaceutical license agreement.
Controlled routing
Routes the same license terms to multiple parties without manually exchanging revised attachments.
Audit trail
Records signer actions, timestamps, and related event information for later contract review.
Record storage
Keeps the executed agreement available with associated completion evidence.
Mobile access
Supports review and signing from signNow mobile apps when authorized users work away from the office.
Named integrations
Connects licensing workflows with systems such as Salesforce, NetSuite, Google Drive, Box, and Microsoft 365.
Security for the license agreement
Stored data:
Data transfer:
Control report:
Security standard:
Electronic signing:
Health data:
Best practices for license agreements
Accurate scope, authorized signatures, controlled access, and complete execution evidence reduce ambiguity when pharmaceutical licensing terms are reviewed later.
Define the licensed rights precisely
Confirm authority before sending
Preserve execution evidence
Secure the final record
Privacy and disclosure pitfalls
Leaving licensed products, territories, fields of use, or exclusivity undefined creates disputes over permitted exploitation. Omitting confidentiality limits can expose proprietary pharmaceutical information to parties without a documented need to know. Using the wrong signer or missing required consent weakens evidence that the company authorized the license. Failing to restrict shared copies can disclose payment terms, research information, or other commercially sensitive provisions.
Risks of incomplete license agreements
Interpretation dispute
Evidence weakness
Confidentiality breach
Contract gap
Processing stages for the license agreement
Use a controlled sequence from drafting through signature and archival so every party receives the same final license terms.
Prepare agreement
Send to signers
Review and sign
Archive record
Key performance indicators that demonstrate SignNow's proven track record.
License agreement troubleshooting
Resolve field, signature, security, and plan questions before sending the License Agreement By And Between Casi Pharmaceuticals, Inc Form.
Upload the agreement as a PDF or supported document, then inspect every auto-detected field. Add missing signature, date, initials, or text fields manually before assigning each field to the correct company representative.
Business includes templates, audit trails, and mobile apps at $8/user/month when billed annually. Business Premium is $15/user/month annually and adds bulk send, kiosk mode, request payments, and quick invite links.
signNow’s ESIGN and UETA compliance supports electronic signatures when intent, consent, attribution, and record retention are established. Review state-specific law and the agreement’s subject matter before relying on electronic execution.
For pharmaceutical information, configure access controls and confirm whether protected health information is involved. signNow states that HIPAA compliance requires a business associate agreement, while confidentiality duties remain contractual responsibilities.
Open the completed document’s audit trail and preserve it with the signed license agreement. The record should connect signer identity, timestamps, IP information, and actions to the final document version.
Business plans include 100 signature invites per user per year, with overage fees. Business Premium adds bulk send, while Site License uses $1.50 per signature invite and supports unlimited users for qualifying volume.
BE READY TO GET MORE
Get this form now!
If you believe that this page should be taken down, please follow our DMCA take-down process.